RECKITT BENCKIS/S (OTCMKTS:RBGLY) Forecasted to Post FY2020 Earnings of $0.83 Per Share

RECKITT BENCKIS/S (OTCMKTS:RBGLY) – Equities research analysts at Jefferies Financial Group dropped their FY2020 earnings estimates for RECKITT BENCKIS/S in a research report issued on Friday, November 15th. Jefferies Financial Group analyst M. Deboo now anticipates that the company will post earnings per share of $0.83 for the year, down from their previous estimate of $0.86. Jefferies Financial Group also issued estimates for RECKITT BENCKIS/S’s FY2021 earnings at $0.84 EPS and FY2022 earnings at $0.86 EPS.

Other equities analysts have also recently issued reports about the company. Berenberg Bank began coverage on RECKITT BENCKIS/S in a research note on Wednesday, October 16th. They issued a “buy” rating on the stock. ValuEngine cut RECKITT BENCKIS/S from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. RECKITT BENCKIS/S has an average rating of “Hold” and a consensus target price of $19.00.

Shares of RECKITT BENCKIS/S stock opened at $15.30 on Monday. The business’s 50 day simple moving average is $15.57 and its two-hundred day simple moving average is $15.81. The stock has a market capitalization of $53.99 billion, a P/E ratio of 17.00, a price-to-earnings-growth ratio of 8.80 and a beta of 0.77. RECKITT BENCKIS/S has a one year low of $14.42 and a one year high of $18.85.

About RECKITT BENCKIS/S

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Further Reading: What is the QQQ ETF?

Earnings History and Estimates for RECKITT BENCKIS/S (OTCMKTS:RBGLY)

Receive News & Ratings for RECKITT BENCKIS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RECKITT BENCKIS/S and related companies with MarketBeat.com's FREE daily email newsletter.